Integral Diagnostics (Australia) Performance
| IDX Stock | 2.46 0.04 1.65% |
The company retains a Market Volatility (i.e., Beta) of 0.12, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Integral Diagnostics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Integral Diagnostics is expected to be smaller as well. At this point, Integral Diagnostics has a negative expected return of -0.17%. Please make sure to check out Integral Diagnostics' skewness, accumulation distribution, and the relationship between the potential upside and kurtosis , to decide if Integral Diagnostics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Integral Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors. ...more
Forward Dividend Yield 0.0269 | Payout Ratio 0.065 | Forward Dividend Rate 0.07 | Ex Dividend Date 2025-08-29 |
1 | Integral Diagnostics Ltd. Announces Quotation of New Securities - MSN | 10/08/2025 |
2 | Macquarie predicts this ASX All Ords healthcare stock to surge past 1 billion over the next 12 months - The Motley Fool Australia | 12/02/2025 |
| Begin Period Cash Flow | 42.4 M | |
| Total Cashflows From Investing Activities | -65 M |
Integral |
Integral Diagnostics Relative Risk vs. Return Landscape
If you would invest 276.00 in Integral Diagnostics on October 1, 2025 and sell it today you would lose (30.00) from holding Integral Diagnostics or give up 10.87% of portfolio value over 90 days. Integral Diagnostics is producing return of less than zero assuming 1.5386% volatility of returns over the 90 days investment horizon. Simply put, 13% of all stocks have less volatile historical return distribution than Integral Diagnostics, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Integral Diagnostics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Integral Diagnostics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Integral Diagnostics, and traders can use it to determine the average amount a Integral Diagnostics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.111
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IDX |
Estimated Market Risk
| 1.54 actual daily | 13 87% of assets are more volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Integral Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Integral Diagnostics by adding Integral Diagnostics to a well-diversified portfolio.
Integral Diagnostics Fundamentals Growth
Integral Stock prices reflect investors' perceptions of the future prospects and financial health of Integral Diagnostics, and Integral Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Integral Stock performance.
| Return On Equity | 0.0097 | ||||
| Return On Asset | 0.0334 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 1.44 B | ||||
| Shares Outstanding | 372.93 M | ||||
| Price To Book | 1.30 X | ||||
| Price To Sales | 1.46 X | ||||
| Revenue | 627.22 M | ||||
| Gross Profit | 195.98 M | ||||
| EBITDA | 87.7 M | ||||
| Net Income | 4.67 M | ||||
| Total Debt | 585.01 M | ||||
| Book Value Per Share | 1.86 X | ||||
| Cash Flow From Operations | 73.77 M | ||||
| Earnings Per Share | 0.02 X | ||||
| Total Asset | 1.43 B | ||||
| Retained Earnings | (37.13 M) | ||||
About Integral Diagnostics Performance
Assessing Integral Diagnostics' fundamental ratios provides investors with valuable insights into Integral Diagnostics' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Integral Diagnostics is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Integral Diagnostics is entity of Australia. It is traded as Stock on AU exchange.Things to note about Integral Diagnostics performance evaluation
Checking the ongoing alerts about Integral Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Integral Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Integral Diagnostics generated a negative expected return over the last 90 days | |
| Integral Diagnostics has high likelihood to experience some financial distress in the next 2 years | |
| Latest headline from news.google.com: Macquarie predicts this ASX All Ords healthcare stock to surge past 1 billion over the next 12 months - The Motley Fool Australia |
- Analyzing Integral Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Integral Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Integral Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Integral Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Integral Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Integral Diagnostics' stock. These opinions can provide insight into Integral Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Integral Stock Analysis
When running Integral Diagnostics' price analysis, check to measure Integral Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integral Diagnostics is operating at the current time. Most of Integral Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integral Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integral Diagnostics' price. Additionally, you may evaluate how the addition of Integral Diagnostics to your portfolios can decrease your overall portfolio volatility.